Following the emergence of the novel coronavirus, more than 1000 clinical trials for non-COVID-19 indications were delayed, put on hold, or even postponed outright. The remarkable recovery in clinical trial participation has been attributed, in part, to the use of technologies and other resources that promote flexibility in how study visits are conducted. Juliet Hulse at Illingworth Research shows three ways in which mobile research nursing is transforming the clinical trial experience.